# FDA recall D-0519-2024

> **Imprimis NJOF, LLC** · Class II · drug recall initiated 2024-05-14.

## Product

Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-640-01

## Reason for recall

Lack of Assurance of Sterility

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0519-2024
- **Recalling firm:** Imprimis NJOF, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-05-14
- **Report date:** 2024-06-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ledgewood, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0519-2024

## Citation

> AI Analytics. FDA recall D-0519-2024. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0519-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*